List of Excipients in API emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Gilead Sciences Inc | ODEFSEY | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 | CELLULOSE, MICROCRYSTALLINE | 2033-02-15 |
Gilead Sciences Inc | ODEFSEY | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 | CROSCARMELLOSE SODIUM | 2033-02-15 |
Gilead Sciences Inc | ODEFSEY | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 | FERROSOFERRIC OXIDE | 2033-02-15 |
Gilead Sciences Inc | ODEFSEY | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 | LACTOSE MONOHYDRATE | 2033-02-15 |
Gilead Sciences Inc | ODEFSEY | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 | MAGNESIUM STEARATE | 2033-02-15 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | 61958-2101 |
>Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.